The study used the activated form of B6 (pyridoxal-5-phosphate, P5P) and the human equivalent dosage was 500mg-600mg. The mechanism of action was the reduction of brain levels of glutamate via activation of glutamate dehydrogenase (GDH).
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317040/
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317040/